Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06835855 · ClinicalTrials.gov registry record · NA

Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression

A NA study of Depression - Major Depressive Disorder, sponsored by Binghamton University.

Recruiting
Registry status
NA
Development phase
225
Enrollment target
1
Study location

NCT06835855: Recruiting NA study of Depression - Major Depressive Disorder, sponsored by Binghamton University.

NCT06835855 is a NA study of Depression - Major Depressive Disorder that is actively recruiting participants, run by Binghamton University. The registered enrollment target is 225 participants, above the 91-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (147% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06835855, a NA study of Depression - Major Depressive Disorder, is actively recruiting participants, sponsored by Binghamton University.

RECRUITING
Registry status
NA
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to examine attentional biases for facial displays of emotion as a mechanism of risk in infants of mothers with postpartum major depression, and the potential role of infant arousal in the development of these attentional biases.

Primary Outcome

Used to determine percent of infant attention allocated to each emotional stimulus type (angry, happy, sad, neutral) during the computer-based task

Interventions

  • OTHER Passive Viewing Task
  • OTHER Interaction Task

Study Locations (1)

New York

  • Binghamton University - Binghamton

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2024-11-14
Est. Completion 2029-07
Phase NA
Binghamton University

7 total trials

What NCT06835855 shows while recruiting

NCT06835855 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, above the 91-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (147% higher).

The record links to 1 condition, with Depression - Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Passive Viewing Task is the first listed.

NCT06835855 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06835855 about?

NCT06835855 is a clinical study titled "Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression". The goal of this study is to examine attentional biases for facial displays of emotion as a mechanism of risk in infants of mothers with postpartum major depression, and the potential role of infant arousal in the development of these attentional biases.

What is the current status of trial NCT06835855?

This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2024-11-14. Estimated completion is 2029-07.

What conditions does trial NCT06835855 study?

This clinical trial studies the following conditions: Depression - Major Depressive Disorder.

What interventions are being tested in trial NCT06835855?

The interventions under investigation include: Passive Viewing Task (OTHER), Interaction Task (OTHER).

Who is sponsoring clinical trial NCT06835855?

This trial is sponsored by Binghamton University, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06835855 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression - Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06835855's enrollment target sits among peer trials

225 2nd of 19 the highest of 19 other Depression - Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression - Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04480554 · 225 participants · Phase 2

    Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06835855, the US trial registry maintained by the National Library of Medicine. NCT06835855 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.